These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19839219)
1. [Discussion on the introductory hearings. Part 3: Following the speech of Professor Donner-Banzhoff]. Köbberling J Z Evid Fortbild Qual Gesundhwes; 2009; 103(6):410-1. PubMed ID: 19839219 [No Abstract] [Full Text] [Related]
2. [Pragmatic trials in a routine care setting]. Donner-Banzhoff N Z Evid Fortbild Qual Gesundhwes; 2009; 103(6):404-9. PubMed ID: 19839218 [TBL] [Abstract][Full Text] [Related]
3. [Discussion of the introductory hearings. Part 1: Subsequent to the delivery of the speech by Professor Wegscheider]. Köbberling J Z Evid Fortbild Qual Gesundhwes; 2009; 103(6):389-90. PubMed ID: 19839215 [No Abstract] [Full Text] [Related]
4. [Discussion on the introductory hearings. Part 2: Following the speech of Professor Schünemann]. Köbberling J Z Evid Fortbild Qual Gesundhwes; 2009; 103(6):401-3. PubMed ID: 19839217 [No Abstract] [Full Text] [Related]
6. Response to Donner-Banzhoff. van den Bruel A; Perera R J Clin Epidemiol; 2014 Feb; 67(2):137. PubMed ID: 24290897 [No Abstract] [Full Text] [Related]
7. Comments on "Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials" by Muller and associates. Satlin A; Rosenkranz G; Pohlmann H J Clin Psychopharmacol; 2003 Dec; 23(6):681. PubMed ID: 14624208 [No Abstract] [Full Text] [Related]
8. Publication bias: its implications for clinical pharmacology. Levy G Clin Pharmacol Ther; 1992 Aug; 52(2):115-9. PubMed ID: 1505146 [No Abstract] [Full Text] [Related]
9. [Sample size and power analyses in clinical trials]. Pripp AH Tidsskr Nor Laegeforen; 2017 Sep; 137(17):. PubMed ID: 28925211 [No Abstract] [Full Text] [Related]
10. Reliability of the modified Rankin Scale: a systematic review. Quinn TJ; Dawson J; Walters MR; Lees KR Stroke; 2009 Oct; 40(10):3393-5. PubMed ID: 19679846 [TBL] [Abstract][Full Text] [Related]
11. Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials. Müller MJ; Szegedi A J Clin Psychopharmacol; 2002 Jun; 22(3):318-25. PubMed ID: 12006903 [TBL] [Abstract][Full Text] [Related]
12. Inadequacy of sample sizes in clinical trials of laboratory parameters attributable to invalid statistical assumptions. Halpern EF Clin Pharmacol Ther; 1994 Oct; 56(4):437-44. PubMed ID: 7955805 [TBL] [Abstract][Full Text] [Related]
13. Numbers treated needlessly. Yeo D Lancet; 2005 Jun 4-10; 365(9475):1926. PubMed ID: 15936417 [No Abstract] [Full Text] [Related]
15. Are large trials less reliable than small trials? Rücker G; Schwarzer G; Schumacher M; Carpenter J J Clin Epidemiol; 2009 Aug; 62(8):886-7; author reply 887-9. PubMed ID: 19481419 [No Abstract] [Full Text] [Related]
16. Trials of community rehabilitation need to be of adequate sample size. Wolfe C; Rudd A; Tilling K Stroke; 1998 Aug; 29(8):1737-9. PubMed ID: 9707221 [No Abstract] [Full Text] [Related]
17. PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question. Gallamini A; Meignan M Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):1-3. PubMed ID: 29026947 [No Abstract] [Full Text] [Related]
18. Interpretation of clinical trial results. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2004 Sep; 82 Suppl 1():S55-61. PubMed ID: 15363695 [TBL] [Abstract][Full Text] [Related]
19. The ethics of sample size: two-sided testing and one-sided thinking. Knottnerus JA; Bouter LM J Clin Epidemiol; 2001 Feb; 54(2):109-10. PubMed ID: 11166523 [No Abstract] [Full Text] [Related]